ELL (gene)

Elongation factor RNA polymerase II
PDB rendering based on 2doa.
Available structures PDB 2doa
Identifiers
Symbols	ELL; C19orf17; DKFZp434I1916; ELL1; MEN
External IDs	OMIM: 600284 MGI: 109377 HomoloGene: 4762 GeneCards: ELL Gene
Gene Ontology Molecular function • protein binding Cellular component • nucleus • nucleoplasm • nucleoplasm • transcription elongation factor complex • Cajal body • nuclear speck Biological process • in utero embryonic development • regulation of transcription, DNA-dependent • transcription from RNA polymerase II promoter • transcription elongation from RNA polymerase II promoter • gene expression • viral reproduction • positive regulation of transcription elongation, DNA-dependent • positive regulation of viral transcription Sources: Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	8178	13716
Ensembl	ENSG00000105656	ENSMUSG00000070002
UniProt	P55199	Q3TXY9
RefSeq (mRNA)	NM_006532	NM_007924.2
RefSeq (protein)	NP_006523	NP_031950.2
Location (UCSC)	Chr 19: 18.55 – 18.63 Mb	Chr 8: 73.06 – 73.12 Mb
PubMed search	[1]	[2]

RNA polymerase II elongation factor ELL is an enzyme that in humans is encoded by the ELL gene.

Interactions

ELL (gene) has been shown to interact with P53.

Further reading

• Iwabuchi K, Bartel PL, Li B, et al. (1994). "Two cellular proteins that bind to wild-type but not mutant p53.". Proc. Natl. Acad. Sci. U.S.A. 91 (13): 6098–102. doi:10.1073/pnas.91.13.6098. PMC 44145. PMID 8016121. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=44145. 
• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298. 
• Shilatifard A, Haque D, Conaway RC, Conaway JW (1997). "Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex". J. Biol. Chem. 272 (35): 22355–63. doi:10.1074/jbc.272.35.22355. PMID 9268387. 
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149. 
• Shilatifard A (1998). "Identification and purification of the Holo-ELL complex. Evidence for the presence of ELL-associated proteins that suppress the transcriptional inhibitory activity of ELL". J. Biol. Chem. 273 (18): 11212–7. doi:10.1074/jbc.273.18.11212. PMID 9556611. 
• Li XY, Green MR (1998). "The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor". Genes Dev. 12 (19): 2992–6. doi:10.1101/gad.12.19.2992. PMC 317190. PMID 9765201. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=317190. 
• Shinobu N, Maeda T, Aso T, et al. (1999). "Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53". J. Biol. Chem. 274 (24): 17003–10. doi:10.1074/jbc.274.24.17003. PMID 10358050. 
• Schmidt AE, Miller T, Schmidt SL, et al. (1999). "Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II". J. Biol. Chem. 274 (31): 21981–5. doi:10.1074/jbc.274.31.21981. PMID 10419521. 
• Kim MK, Nikodem VM (2000). "hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation". Mol. Cell. Biol. 19 (10): 6833–44. PMC 84680. PMID 10490622. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=84680. 
• Lavau C, Luo RT, Du C, Thirman MJ (2000). "Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice". Proc. Natl. Acad. Sci. U.S.A. 97 (20): 10984–9. doi:10.1073/pnas.190167297. PMC 27135. PMID 10995463. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=27135. 
• Wiemann S, Weil B, Wellenreuther R, et al. (2001). "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs". Genome Res. 11 (3): 422–35. doi:10.1101/gr.GR1547R. PMC 311072. PMID 11230166. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=311072. 
• Simone F, Polak PE, Kaberlein JJ, et al. (2001). "EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein". Blood 98 (1): 201–9. doi:10.1182/blood.V98.1.201. PMID 11418481. 
• Luo RT, Lavau C, Du C, et al. (2001). "The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis". Mol. Cell. Biol. 21 (16): 5678–87. doi:10.1128/MCB.21.16.5678-5687.2001. PMC 87288. PMID 11463848. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=87288. 
• Simone F, Luo RT, Polak PE, et al. (2003). "ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties". Blood 101 (6): 2355–62. doi:10.1182/blood-2002-06-1664. PMID 12446457. 
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=139241. 
• Polak PE, Simone F, Kaberlein JJ, et al. (2003). "ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia". Mol. Biol. Cell 14 (4): 1517–28. doi:10.1091/mbc.E02-07-0394. PMC 153119. PMID 12686606. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=153119. 
• Wiederschain D, Kawai H, Gu J, et al. (2003). "Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL". Mol. Cell. Biol. 23 (12): 4230–46. doi:10.1128/MCB.23.12.4230-4246.2003. PMC 156137. PMID 12773566. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=156137. 
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=528928.